Press releases
- Stoke Therapeutics Announces Pricing of Upsized $125 Million Public Offering
- Stoke Therapeutics Announces Proposed Public Offering
- Stoke Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results
- Stoke Therapeutics Announces Landmark New Data That Support the Potential for STK-001 to be the First Disease-Modifying Medicine for the Treatment of Patients with Dravet Syndrome
- Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
- Stoke Therapeutics Highlights Strategic Priorities and Anticipated Milestones for 2024
- Stoke Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
More ▼
Key statistics
On Thursday, Stoke Therapeutics Inc (0GT:FRA) closed at 13.00, 0.00% below its 52-week high of 13.00, set on Mar 27, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 13.00 |
---|---|
High | 13.00 |
Low | 13.00 |
Bid | -- |
Offer | -- |
Previous close | 13.00 |
Average volume | 18.89 |
---|---|
Shares outstanding | 46.30m |
Free float | 42.25m |
P/E (TTM) | -- |
Market cap | 625.10m USD |
EPS (TTM) | -2.38 USD |
Data delayed at least 15 minutes, as of Mar 28 2024 07:02 BST.
More ▼